Alternatives to Signadori Bio
The top Biotechnology companies similar to Signadori Bio, ranked by relevance (named competitors first, then how closely their sectors overlap) and our 0-100 AI-readiness score. Each links to a full profile with funding and team.
ImmunityBio50BiotechnologyCulver City, USA$75.0M
Gilboa Therapeutics43BiopharmaceuticalsTel Aviv, Israel$10.0M
LTZ Therapeutics62BiotechnologyRedwood City, USA$76.0M
Enterome62BiotechnologyParis, France$123.9M
Janux Therapeutics57BiotechnologySan Diego, USA$181.0M
Adaptimmune Therapeutics44BiotechnologyAbingdon, United Kingdom$107.5M
Amgen85BiotechThousand Oaks, United States$40.0M
Moderna77BiotechnologyCambridge, United States$4.5B
BioNTech67BiotechnologyMainz, Germany$975.0M
BeiGene67BiotechCambridge, United States$358.0M- KIKite Pharma65BiotechnologySanta Monica, United States$421.2M
Degron Therapeutics62BiotechnologySan Diego, USA$40.0M
Cartography Biosciences61BiotechnologySouth San Francisco, USA$150.0M
Adcendo61BiotechnologyCopenhagen, Denmark$272.0M
CellCentric60BiotechnologyCambridge, United Kingdom$375.0M- CRCrossbow Therapeutics55BiotechnologyCambridge, United States$157.0M
Ella Therapeutics55Life Sciences$15.0M
ONCOMATRYX51BiotechnologyDerio, Spain$106.8M
Adicet Bio49BiotechBoston, United States$389.0M- LELeman Biotech48BiotechShenzhen, China$22.7M
- GEGenexine47BiotechnologySeoul, South Korea$296.5M
- ANAN2 Therapeutics46BiotechnologyMenlo Park, United States$132.0M
- SISidewinder Therapeutics41BiotechnologySan Diego, USA$137.0M
Aloe Blacc16Biotechnology
Ipsen93BiotechParis, France
Generate Biomedicines71BiotechnologySomerville, United States
Owkin69Artificial IntelligenceNew York, USA$80.0M
4D Path63BiotechnologyNewton, USA$17.4M
STORM Therapeutics62BiotechnologyCambridge, United Kingdom$57.6M
Terremoto Biosciences62BiotechnologySouth San Francisco, USA$108.0M
ParcelBio62BiotechnologySan Francisco, USA$100.0M
Algorithmiq62Quantum ComputingHelsinki, Finland$38.1M
Elicit62Artificial IntelligenceOakland, United States$31.0M
Cue Biopharma, .62BiotechBoston, United States$10.0M
TippingPoint Biosciences61BiotechCambridge, USA$14.5M
Verdiva Bio60BiotechnologySan Diego, United States$170.0M
Alpha Tau Medical60Life SciencesTel Aviv, Israel$100.0M
Celerion59BiotechnologyLincoln, USA$45.0M
Rocket Pharmaceuticals58BiotechnologyCranbury, USA$382.9M- CACasma Therapeutics58BiotechnologyCambridge, United States$46.0M
- LŌLōkahi Therapeutics57BiotechnologyLa Jolla, USA$63.0M
Anagram Therapeutics55BiotechnologyNatick, USA$285.0M
Sinopia Biosciences55BiotechnologySan Diego, USA$2.2M
Travere Therapeutics54BiotechnologySan Diego, USA$63.0M- ANAntiverse54BiotechnologyLondon, United Kingdom$15.7M
Alector54BiotechSouth San Francisco, United States$162.5M
Ray Therapeutics54BiotechnologyBerkeley, USA$243.0M
Tortugas Neuroscience53BiotechnologyFramingham, USA$164.0M
Tharimmune53BiotechCambridge, United States$540.0M
Baccine52Life SciencesBoston, United States$15.0M
MindWave Innovations51Biotechnology$100.0M
Pyxis Diagnostics51HealthcareSan Diego, United States$10.0M- ADAdvanced Accelerator Applications50PharmaceuticalsSaint-Genis-Pouilly, France$56.4M
EnteroBiotix50BiotechnologyGlasgow, United Kingdom$40.5M
Braeburn50BiotechPlymouth Meeting, United States$133.0M- ARargenx49BiTechAmsterdam, Netherlands$51.1M
Ternary Therapeutics49BiotechnologyLondon, United Kingdom$4.3M- CECentauri Therapeutics49BiotechnologyOxford, United Kingdom$57.2M
BioLamina49BiotechnologyStockholm, Sweden$41.9M
Orthogon Therapeutics49BiotechnologyCanton, USA$34.6M
| Company | Sector | HQ | Funding | Score |
|---|---|---|---|---|
| Biotechnology | Culver City, USA | $75.0M | 50 | |
| Biopharmaceuticals | Tel Aviv, Israel | $10.0M | 43 | |
| Biotechnology | Redwood City, USA | $76.0M | 62 | |
| Biotechnology | Paris, France | $123.9M | 62 | |
| Biotechnology | San Diego, USA | $181.0M | 57 | |
| Biotechnology | Abingdon, United Kingdom | $107.5M | 44 | |
| Biotech | Thousand Oaks, United States | $40.0M | 85 | |
| Biotechnology | Cambridge, United States | $4.5B | 77 | |
| Biotechnology | Mainz, Germany | $975.0M | 67 | |
| Biotech | Cambridge, United States | $358.0M | 67 | |
| KIKite Pharma | Biotechnology | Santa Monica, United States | $421.2M | 65 |
| Biotechnology | San Diego, USA | $40.0M | 62 | |
| Biotechnology | South San Francisco, USA | $150.0M | 61 | |
| Biotechnology | Copenhagen, Denmark | $272.0M | 61 | |
| Biotechnology | Cambridge, United Kingdom | $375.0M | 60 | |
| CRCrossbow Therapeutics | Biotechnology | Cambridge, United States | $157.0M | 55 |
| Life Sciences | — | $15.0M | 55 | |
| Biotechnology | Derio, Spain | $106.8M | 51 | |
| Biotech | Boston, United States | $389.0M | 49 | |
| LELeman Biotech | Biotech | Shenzhen, China | $22.7M | 48 |
| GEGenexine | Biotechnology | Seoul, South Korea | $296.5M | 47 |
| ANAN2 Therapeutics | Biotechnology | Menlo Park, United States | $132.0M | 46 |
| SISidewinder Therapeutics | Biotechnology | San Diego, USA | $137.0M | 41 |
| Biotechnology | — | — | 16 | |
| Biotech | Paris, France | — | 93 | |
| Biotechnology | Somerville, United States | — | 71 | |
| Artificial Intelligence | New York, USA | $80.0M | 69 | |
| Biotechnology | Newton, USA | $17.4M | 63 | |
| Biotechnology | Cambridge, United Kingdom | $57.6M | 62 | |
| Biotechnology | South San Francisco, USA | $108.0M | 62 | |
| Biotechnology | San Francisco, USA | $100.0M | 62 | |
| Quantum Computing | Helsinki, Finland | $38.1M | 62 | |
| Artificial Intelligence | Oakland, United States | $31.0M | 62 | |
| Biotech | Boston, United States | $10.0M | 62 | |
| Biotech | Cambridge, USA | $14.5M | 61 | |
| Biotechnology | San Diego, United States | $170.0M | 60 | |
| Life Sciences | Tel Aviv, Israel | $100.0M | 60 | |
| Biotechnology | Lincoln, USA | $45.0M | 59 | |
| Biotechnology | Cranbury, USA | $382.9M | 58 | |
| CACasma Therapeutics | Biotechnology | Cambridge, United States | $46.0M | 58 |
| LŌLōkahi Therapeutics | Biotechnology | La Jolla, USA | $63.0M | 57 |
| Biotechnology | Natick, USA | $285.0M | 55 | |
| Biotechnology | San Diego, USA | $2.2M | 55 | |
| Biotechnology | San Diego, USA | $63.0M | 54 | |
| ANAntiverse | Biotechnology | London, United Kingdom | $15.7M | 54 |
| Biotech | South San Francisco, United States | $162.5M | 54 | |
| Biotechnology | Berkeley, USA | $243.0M | 54 | |
| Biotechnology | Framingham, USA | $164.0M | 53 | |
| Biotech | Cambridge, United States | $540.0M | 53 | |
| Life Sciences | Boston, United States | $15.0M | 52 | |
| Biotechnology | — | $100.0M | 51 | |
| Healthcare | San Diego, United States | $10.0M | 51 | |
| ADAdvanced Accelerator Applications | Pharmaceuticals | Saint-Genis-Pouilly, France | $56.4M | 50 |
| Biotechnology | Glasgow, United Kingdom | $40.5M | 50 | |
| Biotech | Plymouth Meeting, United States | $133.0M | 50 | |
| ARargenx | BiTech | Amsterdam, Netherlands | $51.1M | 49 |
| Biotechnology | London, United Kingdom | $4.3M | 49 | |
| CECentauri Therapeutics | Biotechnology | Oxford, United Kingdom | $57.2M | 49 |
| Biotechnology | Stockholm, Sweden | $41.9M | 49 | |
| Biotechnology | Canton, USA | $34.6M | 49 |